ZYLOXTB spends HKD 1.11 million to repurchase 62,500 H shares, lifting treasury stock to 12.17 million

Bulletin Express

Jun 25

Zylox-Tonbridge Medical Technology Co., Ltd. (abbreviated as ZYLOXTB) disclosed a share repurchase executed on 25 June 2026 under its existing mandate.

The company bought back 62,500 H shares on the Hong Kong Stock Exchange at prices ranging from HKD 17.57 to HKD 18.07, for a volume-weighted average of HKD 17.78 per share. The aggregate consideration amounted to HKD 1.11 million.

Following the transaction, issued shares outstanding (excluding treasury shares) decreased to 324.18 million, while treasury shares rose to 12.17 million. Total issued share capital remained unchanged at 336.35 million shares.

The repurchase forms part of the mandate approved on 13 May 2026, which authorises ZYLOXTB to buy back up to 32.72 million shares. Cumulative repurchases under this mandate now stand at 3.02 million shares, representing 0.90% of the company’s issued shares on the mandate date.

In line with Hong Kong listing rules, ZYLOXTB is subject to a moratorium on issuing new shares or selling treasury shares until 25 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1173769992"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1173769992\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1173769992?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-25 18:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173769992","market":"hk","top_or_hot":-1,"title":"ZYLOXTB spends HKD 1.11 million to repurchase 62,500 H shares, lifting treasury stock to 12.17 million","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (abbreviated as ZYLOXTB) disclosed a share repurchase executed on 25 June 2026 under its existing mandate.</p>\n<p>The company bought back 62,500 H shares on the Hong Kong Stock Exchange at prices ranging from HKD 17.57 to HKD 18.07, for a volume-weighted average of HKD 17.78 per share. The aggregate consideration amounted to HKD 1.11 million.</p>\n<p>Following the transaction, issued shares outstanding (excluding treasury shares) decreased to 324.18 million, while treasury shares rose to 12.17 million. Total issued share capital remained unchanged at 336.35 million shares.</p>\n<p>The repurchase forms part of the mandate approved on 13 May 2026, which authorises ZYLOXTB to buy back up to 32.72 million shares. Cumulative repurchases under this mandate now stand at 3.02 million shares, representing 0.90% of the company’s issued shares on the mandate date.</p>\n<p>In line with Hong Kong listing rules, ZYLOXTB is subject to a moratorium on issuing new shares or selling treasury shares until 25 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZYLOXTB spends HKD 1.11 million to repurchase 62,500 H shares, lifting treasury stock to 12.17 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZYLOXTB spends HKD 1.11 million to repurchase 62,500 H shares, lifting treasury stock to 12.17 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-25 18:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (abbreviated as ZYLOXTB) disclosed a share repurchase executed on 25 June 2026 under its existing mandate.</p>\n<p>The company bought back 62,500 H shares on the Hong Kong Stock Exchange at prices ranging from HKD 17.57 to HKD 18.07, for a volume-weighted average of HKD 17.78 per share. The aggregate consideration amounted to HKD 1.11 million.</p>\n<p>Following the transaction, issued shares outstanding (excluding treasury shares) decreased to 324.18 million, while treasury shares rose to 12.17 million. Total issued share capital remained unchanged at 336.35 million shares.</p>\n<p>The repurchase forms part of the mandate approved on 13 May 2026, which authorises ZYLOXTB to buy back up to 32.72 million shares. Cumulative repurchases under this mandate now stand at 3.02 million shares, representing 0.90% of the company’s issued shares on the mandate date.</p>\n<p>In line with Hong Kong listing rules, ZYLOXTB is subject to a moratorium on issuing new shares or selling treasury shares until 25 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1173769992","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173769992","pubTimestamp":1782383237,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (abbreviated as ZYLOXTB) disclosed a share repurchase executed on 25 June 2026 under its existing mandate. The company bought back 62,500 H shares on the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"ZYLOXTB斥资111万港元回购6.25万股H股库存股增至1217万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (abbreviated as ZYLOXTB) disclosed a share repurchase executed on 25 June 2026 under its existing mandate.\nThe company bought back 62,500 H shares on the Hong Kong Stock Exchange at prices ranging from HKD 17.57 to HKD 18.07, for a volume-weighted average of HKD 17.78 per share. The aggregate consideration amounted to HKD 1.11 million.\nFollowing the transaction, issued shares outstanding (excluding treasury shares) decreased to 324.18 million, while treasury shares rose to 12.17 million. Total issued share capital remained unchanged at 336.35 million shares.\nThe repurchase forms part of the mandate approved on 13 May 2026, which authorises ZYLOXTB to buy back up to 32.72 million shares. Cumulative repurchases under this mandate now stand at 3.02 million shares, representing 0.90% of the company’s issued shares on the mandate date.\nIn line with Hong Kong listing rules, ZYLOXTB is subject to a moratorium on issuing new shares or selling treasury shares until 25 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}